Nicotinamide riboside (NR)
Nicotinamide Riboside (NR / Niagen) · also known as Niagen, Nicotinamide riboside chloride, NR
NR is phosphorylated by NRK1/2 to form NMN, which is then converted to NAD+. Randomized human trials showed a marked rise in whole-blood NAD+ after oral intake. But the SIRT3-related mechanism comes mainly from animal experiments, and human evidence is lacking for long-term safety and anti-aging benefit.
Clinical uses and human evidence
Age-related cognitive decline
Blood sugar and insulin resistance
Studies (2)
- Dollerup 2018 · Am J Clin Nutr · RCT · n=40 — A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects
- Remie 2020 · Am J Clin Nutr · randomized crossover trial · n=13 — Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans
Body weight and body fat
Mechanisms of action
Replenishing the NAD+ pool via the salvage pathway
NR is phosphorylated by NRK1/NRK2 to form NMN, which is then converted to NAD+. In a human randomized trial, 100, 300 and 1000 mg/day raised whole-blood NAD+ by an average of about 22%, 51% and 142%, respectively. This result comes from blood, and the size of the increase differs between tissues.
Sirtuin-dependent protein deacetylase activation
The NAD+ supplied by NR is an essential substrate for sirtuin reactions. In theory it could drive SIRT3 deacetylation, which in turn activates the mitochondrial antioxidant enzyme SOD2. This chain comes mainly from animal and cell studies. Higher blood NAD+ in humans does not prove that SIRT3 activity in tissues rose at the same time.